Insulet FY2026 Adj EPS expected to be more than $6.46 vs $6.43 Est; Lowers FY2026 Sales Guidance from $3.277B-$3.331B to $3.250B-$3.304B vs $3.321B Est

Benzinga Newsdesk www.benzinga.com Positive 86.2%

Neg 0% Neu 0% Pos 86.2%

Insulet (NASDAQ:PODD) FY2026 expected to be more than $6.46 vs $6.43 Est. lowers FY2026 sales outlook from $3.277 billion-$3.331 billion to $3.250 billion-$3.304 billion vs $3.321 billion estimate.